Revvity
Steve Willoughby serves as the Senior Vice President of Investor Relations, ESG, and Corporate Risk Management at Revvity since 2021, overseeing a comprehensive Investor Relations strategy for a company with a market cap of approximately $15 billion. Prior to this role, Steve held the position of Vice President of Investor Relations at Cleveland Research Company from June 2006 to May 2021, where the founding member contributed to equity research focused on Life Science Tools, Managed Care, Ophthalmology, and Cosmetic Surgery sectors. Steve began a career in finance as a Research Associate at FTN Midwest Securities from 2003 to June 2006. Steve earned a Bachelor of Science degree in Finance from Miami University Farmer School of Business between 1999 and 2003.
This person is not in any teams
This person is not in any offices
Revvity
8 followers
At Revvity, “impossible” is inspiration, and ""can't be done"" is a call to action. Revvity provides health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure. Revvity is revolutionizing what’s possible in healthcare, with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more. With more than $3 billion in revenue and over 11,000 employees, Revvity serves customers across pharmaceutical and biotech, diagnostic labs, academia and governments. It is part of the S&P 500 index and has customers in more than 190 countries. Learn more at www.revvity.com